About Bikanta
Bikanta is a company based in Berkeley (United States) founded in 2013.. Bikanta has raised $120 thousand across 1 funding round from investors including Y Combinator. The company has 6 employees as of December 31, 2021. Bikanta offers products and services including Optical Imaging Technology and Biotech Research Platforms. Bikanta operates in a competitive market with competitors including Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others.
- Headquarter Berkeley, United States
- Employees 6 as on 31 Dec, 2021
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Bikanta
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$120 K (USD)
in 1 rounds
-
Latest Funding Round
$120 K (USD), Seed
Jul 16, 2014
- Investors
-
Employee Count
6
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bikanta
Bikanta offers a comprehensive portfolio of products and services, including Optical Imaging Technology and Biotech Research Platforms. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Provides tools for molecular-level biological imaging and analysis
Offers platforms for cellular-level medical diagnostics and innovation
Unlock access to complete
Unlock access to complete
Unlock access to complete
Funding Insights of Bikanta
Bikanta has successfully raised a total of $120K through 1 strategic funding round. The most recent funding activity was a Seed round of $120 thousand completed in July 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $120,000
-
First Round
First Round
(16 Jul 2014)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2014 | Amount | Seed - Bikanta | Valuation | Y Combinator |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Bikanta
Bikanta has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bikanta
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Bikanta
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bikanta Comparisons
Competitors of Bikanta
Bikanta operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Denali Therapeutics, MiRagen, Poseida Therapeutics, Juno Therapeutics and Castle Biosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Neurodegenerative disease therapies are developed for Alzheimer's, ALS, and Parkinson's.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies for treating cancer and liver orphan disease by using gene editing technologies
|
|
| domain | founded_year | HQ Location |
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
|
|
| domain | founded_year | HQ Location |
Precision diagnostic and prognostic tests are developed by Castle Biosciences.
|
|
| domain | founded_year | HQ Location |
Proprietary lab-on-chip platform for nanoparticle isolation is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Bikanta
When was Bikanta founded?
Bikanta was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Bikanta located?
Bikanta is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Is Bikanta a funded company?
Bikanta is a funded company, having raised a total of $120K across 1 funding round to date. The company's 1st funding round was a Seed of $120K, raised on Jul 16, 2014.
How many employees does Bikanta have?
As of Dec 31, 2021, the latest employee count at Bikanta is 6.
What does Bikanta do?
Bikanta was founded in 2013 in Berkeley, United States, within the biotechnology sector. Nanodiamond-based molecular probes are developed by the company for cancer imaging, featuring fluorescence, stability, and non-toxicity for background-free optical detection. These probes are coated with customizable layers that can be bound to aptamers, biotin, DNA, antibodies, or other moieties for targeted diagnostics. Custom scanners are also being developed for probe detection, with initial focus on metastatic microtumors.
Who are the top competitors of Bikanta?
Bikanta's top competitors include Juno Therapeutics, Personalis and Poseida Therapeutics.
What products or services does Bikanta offer?
Bikanta offers Optical Imaging Technology and Biotech Research Platforms.
Who are Bikanta's investors?
Bikanta has 1 investor. Key investors include Y Combinator.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.